nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B1—Verapamil—migraine	0.27	0.532	CbGbCtD
Olmesartan—ABCC2—Verapamil—migraine	0.237	0.468	CbGbCtD
Olmesartan—Irbesartan—EDNRA—migraine	0.00806	0.801	CrCbGaD
Olmesartan—AGTR1—ACE Inhibitor Pathway—ACE—migraine	0.0029	0.0887	CbGpPWpGaD
Olmesartan—Losartan—ACE—migraine	0.002	0.199	CrCbGaD
Olmesartan—AGTR1—Peptide GPCRs—EDNRA—migraine	0.000949	0.029	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—HTR2B—migraine	0.000767	0.0234	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000686	0.0209	CbGpPWpGaD
Olmesartan—Urinary tract disorder—Gabapentin—migraine	0.000665	0.00148	CcSEcCtD
Olmesartan—Oedema peripheral—Gabapentin—migraine	0.000663	0.00147	CcSEcCtD
Olmesartan—Neutropenia—Topiramate—migraine	0.000662	0.00147	CcSEcCtD
Olmesartan—Connective tissue disorder—Gabapentin—migraine	0.000662	0.00147	CcSEcCtD
Olmesartan—Urethral disorder—Gabapentin—migraine	0.00066	0.00147	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Topiramate—migraine	0.000658	0.00146	CcSEcCtD
Olmesartan—Ill-defined disorder—Valproic Acid—migraine	0.000656	0.00146	CcSEcCtD
Olmesartan—Angiopathy—Timolol—migraine	0.000656	0.00146	CcSEcCtD
Olmesartan—Anaemia—Valproic Acid—migraine	0.000654	0.00145	CcSEcCtD
Olmesartan—Erectile dysfunction—Topiramate—migraine	0.000652	0.00145	CcSEcCtD
Olmesartan—Mediastinal disorder—Timolol—migraine	0.000652	0.00145	CcSEcCtD
Olmesartan—Agitation—Valproic Acid—migraine	0.00065	0.00144	CcSEcCtD
Olmesartan—Urticaria—Verapamil—migraine	0.000647	0.00144	CcSEcCtD
Olmesartan—Angioedema—Valproic Acid—migraine	0.000646	0.00144	CcSEcCtD
Olmesartan—Photosensitivity reaction—Topiramate—migraine	0.000646	0.00144	CcSEcCtD
Olmesartan—Arrhythmia—Timolol—migraine	0.000646	0.00144	CcSEcCtD
Olmesartan—Nausea—Amitriptyline—migraine	0.000645	0.00143	CcSEcCtD
Olmesartan—Alopecia—Timolol—migraine	0.000639	0.00142	CcSEcCtD
Olmesartan—Hyperglycaemia—Topiramate—migraine	0.000638	0.00142	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000638	0.0195	CbGpPWpGaD
Olmesartan—Malaise—Valproic Acid—migraine	0.000638	0.00142	CcSEcCtD
Olmesartan—Vertigo—Valproic Acid—migraine	0.000635	0.00141	CcSEcCtD
Olmesartan—Asthenia—Propranolol—migraine	0.000635	0.00141	CcSEcCtD
Olmesartan—Pneumonia—Topiramate—migraine	0.000635	0.00141	CcSEcCtD
Olmesartan—Mental disorder—Timolol—migraine	0.000633	0.00141	CcSEcCtD
Olmesartan—Leukopenia—Valproic Acid—migraine	0.000633	0.00141	CcSEcCtD
Olmesartan—Infestation NOS—Topiramate—migraine	0.000631	0.0014	CcSEcCtD
Olmesartan—Infestation—Topiramate—migraine	0.000631	0.0014	CcSEcCtD
Olmesartan—Malnutrition—Timolol—migraine	0.000629	0.0014	CcSEcCtD
Olmesartan—Palpitations—Valproic Acid—migraine	0.000625	0.00139	CcSEcCtD
Olmesartan—Renal failure—Topiramate—migraine	0.00062	0.00138	CcSEcCtD
Olmesartan—Cough—Valproic Acid—migraine	0.000617	0.00137	CcSEcCtD
Olmesartan—Urinary tract infection—Topiramate—migraine	0.000613	0.00136	CcSEcCtD
Olmesartan—Mediastinal disorder—Gabapentin—migraine	0.000607	0.00135	CcSEcCtD
Olmesartan—Diarrhoea—Propranolol—migraine	0.000605	0.00135	CcSEcCtD
Olmesartan—Myalgia—Valproic Acid—migraine	0.000602	0.00134	CcSEcCtD
Olmesartan—Chest pain—Valproic Acid—migraine	0.000602	0.00134	CcSEcCtD
Olmesartan—Arthralgia—Valproic Acid—migraine	0.000602	0.00134	CcSEcCtD
Olmesartan—Haematuria—Topiramate—migraine	0.000602	0.00134	CcSEcCtD
Olmesartan—Anxiety—Valproic Acid—migraine	0.0006	0.00133	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000598	0.00133	CcSEcCtD
Olmesartan—Alopecia—Gabapentin—migraine	0.000595	0.00132	CcSEcCtD
Olmesartan—Discomfort—Valproic Acid—migraine	0.000595	0.00132	CcSEcCtD
Olmesartan—Vision blurred—Timolol—migraine	0.000593	0.00132	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000593	0.0181	CbGpPWpGaD
Olmesartan—Sinusitis—Topiramate—migraine	0.000592	0.00132	CcSEcCtD
Olmesartan—Mental disorder—Gabapentin—migraine	0.00059	0.00131	CcSEcCtD
Olmesartan—Agranulocytosis—Topiramate—migraine	0.000589	0.00131	CcSEcCtD
Olmesartan—Malnutrition—Gabapentin—migraine	0.000586	0.0013	CcSEcCtD
Olmesartan—Dizziness—Propranolol—migraine	0.000585	0.0013	CcSEcCtD
Olmesartan—Asthenia—Verapamil—migraine	0.000584	0.0013	CcSEcCtD
Olmesartan—Anaphylactic shock—Valproic Acid—migraine	0.000577	0.00128	CcSEcCtD
Olmesartan—Oedema—Valproic Acid—migraine	0.000577	0.00128	CcSEcCtD
Olmesartan—Pruritus—Verapamil—migraine	0.000576	0.00128	CcSEcCtD
Olmesartan—Angioedema—Timolol—migraine	0.000575	0.00128	CcSEcCtD
Olmesartan—Infection—Valproic Acid—migraine	0.000573	0.00127	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—RAMP1—migraine	0.000573	0.0175	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CALCRL—migraine	0.000573	0.0175	CbGpPWpGaD
Olmesartan—Rhinitis—Topiramate—migraine	0.000568	0.00126	CcSEcCtD
Olmesartan—Back pain—Gabapentin—migraine	0.000567	0.00126	CcSEcCtD
Olmesartan—Nervous system disorder—Valproic Acid—migraine	0.000566	0.00126	CcSEcCtD
Olmesartan—Vertigo—Timolol—migraine	0.000566	0.00126	CcSEcCtD
Olmesartan—Thrombocytopenia—Valproic Acid—migraine	0.000565	0.00126	CcSEcCtD
Olmesartan—Syncope—Timolol—migraine	0.000564	0.00125	CcSEcCtD
Olmesartan—Muscle spasms—Gabapentin—migraine	0.000564	0.00125	CcSEcCtD
Olmesartan—Tachycardia—Valproic Acid—migraine	0.000563	0.00125	CcSEcCtD
Olmesartan—Vomiting—Propranolol—migraine	0.000563	0.00125	CcSEcCtD
Olmesartan—Pharyngitis—Topiramate—migraine	0.000562	0.00125	CcSEcCtD
Olmesartan—Skin disorder—Valproic Acid—migraine	0.000561	0.00125	CcSEcCtD
Olmesartan—Urinary tract disorder—Topiramate—migraine	0.000559	0.00124	CcSEcCtD
Olmesartan—Oedema peripheral—Topiramate—migraine	0.000558	0.00124	CcSEcCtD
Olmesartan—Hyperhidrosis—Valproic Acid—migraine	0.000558	0.00124	CcSEcCtD
Olmesartan—Rash—Propranolol—migraine	0.000558	0.00124	CcSEcCtD
Olmesartan—Dermatitis—Propranolol—migraine	0.000557	0.00124	CcSEcCtD
Olmesartan—Diarrhoea—Verapamil—migraine	0.000557	0.00124	CcSEcCtD
Olmesartan—Connective tissue disorder—Topiramate—migraine	0.000557	0.00124	CcSEcCtD
Olmesartan—Palpitations—Timolol—migraine	0.000556	0.00124	CcSEcCtD
Olmesartan—Urethral disorder—Topiramate—migraine	0.000555	0.00123	CcSEcCtD
Olmesartan—Loss of consciousness—Timolol—migraine	0.000553	0.00123	CcSEcCtD
Olmesartan—Vision blurred—Gabapentin—migraine	0.000552	0.00123	CcSEcCtD
Olmesartan—Anorexia—Valproic Acid—migraine	0.00055	0.00122	CcSEcCtD
Olmesartan—Cough—Timolol—migraine	0.000549	0.00122	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000546	0.0167	CbGpPWpGaD
Olmesartan—Ill-defined disorder—Gabapentin—migraine	0.000544	0.00121	CcSEcCtD
Olmesartan—Anaemia—Gabapentin—migraine	0.000542	0.0012	CcSEcCtD
Olmesartan—Hypotension—Valproic Acid—migraine	0.000539	0.0012	CcSEcCtD
Olmesartan—Agitation—Gabapentin—migraine	0.000539	0.0012	CcSEcCtD
Olmesartan—Dizziness—Verapamil—migraine	0.000538	0.0012	CcSEcCtD
Olmesartan—Myalgia—Timolol—migraine	0.000536	0.00119	CcSEcCtD
Olmesartan—Arthralgia—Timolol—migraine	0.000536	0.00119	CcSEcCtD
Olmesartan—Chest pain—Timolol—migraine	0.000536	0.00119	CcSEcCtD
Olmesartan—Angioedema—Gabapentin—migraine	0.000536	0.00119	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—TRPM8—migraine	0.000535	0.0163	CbGpPWpGaD
Olmesartan—Anxiety—Timolol—migraine	0.000534	0.00119	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000532	0.00118	CcSEcCtD
Olmesartan—Discomfort—Timolol—migraine	0.000529	0.00118	CcSEcCtD
Olmesartan—Malaise—Gabapentin—migraine	0.000529	0.00117	CcSEcCtD
Olmesartan—Vertigo—Gabapentin—migraine	0.000527	0.00117	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Valproic Acid—migraine	0.000526	0.00117	CcSEcCtD
Olmesartan—Syncope—Gabapentin—migraine	0.000526	0.00117	CcSEcCtD
Olmesartan—Nausea—Propranolol—migraine	0.000526	0.00117	CcSEcCtD
Olmesartan—Leukopenia—Gabapentin—migraine	0.000525	0.00117	CcSEcCtD
Olmesartan—Insomnia—Valproic Acid—migraine	0.000522	0.00116	CcSEcCtD
Olmesartan—Palpitations—Gabapentin—migraine	0.000518	0.00115	CcSEcCtD
Olmesartan—Vomiting—Verapamil—migraine	0.000517	0.00115	CcSEcCtD
Olmesartan—Loss of consciousness—Gabapentin—migraine	0.000515	0.00114	CcSEcCtD
Olmesartan—Angiopathy—Topiramate—migraine	0.000514	0.00114	CcSEcCtD
Olmesartan—Oedema—Timolol—migraine	0.000514	0.00114	CcSEcCtD
Olmesartan—Anaphylactic shock—Timolol—migraine	0.000514	0.00114	CcSEcCtD
Olmesartan—Rash—Verapamil—migraine	0.000513	0.00114	CcSEcCtD
Olmesartan—Dermatitis—Verapamil—migraine	0.000513	0.00114	CcSEcCtD
Olmesartan—Cough—Gabapentin—migraine	0.000511	0.00114	CcSEcCtD
Olmesartan—Mediastinal disorder—Topiramate—migraine	0.000511	0.00113	CcSEcCtD
Olmesartan—Infection—Timolol—migraine	0.00051	0.00113	CcSEcCtD
Olmesartan—Headache—Verapamil—migraine	0.00051	0.00113	CcSEcCtD
Olmesartan—Dyspepsia—Valproic Acid—migraine	0.000508	0.00113	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000508	0.0155	CbGpPWpGaD
Olmesartan—Shock—Timolol—migraine	0.000505	0.00112	CcSEcCtD
Olmesartan—Nervous system disorder—Timolol—migraine	0.000504	0.00112	CcSEcCtD
Olmesartan—Decreased appetite—Valproic Acid—migraine	0.000502	0.00111	CcSEcCtD
Olmesartan—Alopecia—Topiramate—migraine	0.000501	0.00111	CcSEcCtD
Olmesartan—Chest pain—Gabapentin—migraine	0.000499	0.00111	CcSEcCtD
Olmesartan—Arthralgia—Gabapentin—migraine	0.000499	0.00111	CcSEcCtD
Olmesartan—Myalgia—Gabapentin—migraine	0.000499	0.00111	CcSEcCtD
Olmesartan—Skin disorder—Timolol—migraine	0.000499	0.00111	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Valproic Acid—migraine	0.000498	0.00111	CcSEcCtD
Olmesartan—Fatigue—Valproic Acid—migraine	0.000498	0.00111	CcSEcCtD
Olmesartan—Anxiety—Gabapentin—migraine	0.000497	0.00111	CcSEcCtD
Olmesartan—Hyperhidrosis—Timolol—migraine	0.000497	0.0011	CcSEcCtD
Olmesartan—Mental disorder—Topiramate—migraine	0.000496	0.0011	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000496	0.0011	CcSEcCtD
Olmesartan—Constipation—Valproic Acid—migraine	0.000493	0.0011	CcSEcCtD
Olmesartan—Pain—Valproic Acid—migraine	0.000493	0.0011	CcSEcCtD
Olmesartan—Malnutrition—Topiramate—migraine	0.000493	0.0011	CcSEcCtD
Olmesartan—Discomfort—Gabapentin—migraine	0.000493	0.0011	CcSEcCtD
Olmesartan—Anorexia—Timolol—migraine	0.00049	0.00109	CcSEcCtD
Olmesartan—Nausea—Verapamil—migraine	0.000483	0.00107	CcSEcCtD
Olmesartan—Hypotension—Timolol—migraine	0.00048	0.00107	CcSEcCtD
Olmesartan—Anaphylactic shock—Gabapentin—migraine	0.000478	0.00106	CcSEcCtD
Olmesartan—Oedema—Gabapentin—migraine	0.000478	0.00106	CcSEcCtD
Olmesartan—Back pain—Topiramate—migraine	0.000477	0.00106	CcSEcCtD
Olmesartan—Feeling abnormal—Valproic Acid—migraine	0.000476	0.00106	CcSEcCtD
Olmesartan—Infection—Gabapentin—migraine	0.000475	0.00106	CcSEcCtD
Olmesartan—Muscle spasms—Topiramate—migraine	0.000474	0.00105	CcSEcCtD
Olmesartan—AGTR1—G alpha (q) signalling events—NPS—migraine	0.000474	0.0145	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—TAC1—migraine	0.000474	0.0145	CbGpPWpGaD
Olmesartan—Gastrointestinal pain—Valproic Acid—migraine	0.000472	0.00105	CcSEcCtD
Olmesartan—Shock—Gabapentin—migraine	0.000471	0.00105	CcSEcCtD
Olmesartan—Nervous system disorder—Gabapentin—migraine	0.000469	0.00104	CcSEcCtD
Olmesartan—Thrombocytopenia—Gabapentin—migraine	0.000468	0.00104	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Timolol—migraine	0.000468	0.00104	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—TAC1—migraine	0.000468	0.0143	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—NPS—migraine	0.000468	0.0143	CbGpPWpGaD
Olmesartan—Tachycardia—Gabapentin—migraine	0.000467	0.00104	CcSEcCtD
Olmesartan—Vision blurred—Topiramate—migraine	0.000465	0.00103	CcSEcCtD
Olmesartan—Skin disorder—Gabapentin—migraine	0.000465	0.00103	CcSEcCtD
Olmesartan—AGTR1—G alpha (q) signalling events—HTR2C—migraine	0.000465	0.0142	CbGpPWpGaD
Olmesartan—Insomnia—Timolol—migraine	0.000465	0.00103	CcSEcCtD
Olmesartan—Hyperhidrosis—Gabapentin—migraine	0.000462	0.00103	CcSEcCtD
Olmesartan—Urticaria—Valproic Acid—migraine	0.000458	0.00102	CcSEcCtD
Olmesartan—Ill-defined disorder—Topiramate—migraine	0.000458	0.00102	CcSEcCtD
Olmesartan—Body temperature increased—Valproic Acid—migraine	0.000456	0.00101	CcSEcCtD
Olmesartan—Abdominal pain—Valproic Acid—migraine	0.000456	0.00101	CcSEcCtD
Olmesartan—Anorexia—Gabapentin—migraine	0.000456	0.00101	CcSEcCtD
Olmesartan—Anaemia—Topiramate—migraine	0.000456	0.00101	CcSEcCtD
Olmesartan—Agitation—Topiramate—migraine	0.000453	0.00101	CcSEcCtD
Olmesartan—Dyspepsia—Timolol—migraine	0.000452	0.001	CcSEcCtD
Olmesartan—AGTR1—G alpha (q) signalling events—EDNRA—migraine	0.000452	0.0138	CbGpPWpGaD
Olmesartan—Hypotension—Gabapentin—migraine	0.000447	0.000993	CcSEcCtD
Olmesartan—Decreased appetite—Timolol—migraine	0.000447	0.000992	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—EDNRA—migraine	0.000446	0.0136	CbGpPWpGaD
Olmesartan—Malaise—Topiramate—migraine	0.000445	0.000988	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Timolol—migraine	0.000443	0.000986	CcSEcCtD
Olmesartan—Vertigo—Topiramate—migraine	0.000443	0.000985	CcSEcCtD
Olmesartan—Fatigue—Timolol—migraine	0.000443	0.000984	CcSEcCtD
Olmesartan—Syncope—Topiramate—migraine	0.000442	0.000983	CcSEcCtD
Olmesartan—Leukopenia—Topiramate—migraine	0.000441	0.000981	CcSEcCtD
Olmesartan—Pain—Timolol—migraine	0.000439	0.000976	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Gabapentin—migraine	0.000436	0.000968	CcSEcCtD
Olmesartan—Palpitations—Topiramate—migraine	0.000436	0.000968	CcSEcCtD
Olmesartan—Loss of consciousness—Topiramate—migraine	0.000433	0.000963	CcSEcCtD
Olmesartan—Insomnia—Gabapentin—migraine	0.000433	0.000961	CcSEcCtD
Olmesartan—Cough—Topiramate—migraine	0.00043	0.000956	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000424	0.0129	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000424	0.0129	CbGpPWpGaD
Olmesartan—Feeling abnormal—Timolol—migraine	0.000423	0.000941	CcSEcCtD
Olmesartan—Dyspepsia—Gabapentin—migraine	0.000421	0.000936	CcSEcCtD
Olmesartan—Gastrointestinal pain—Timolol—migraine	0.00042	0.000933	CcSEcCtD
Olmesartan—Chest pain—Topiramate—migraine	0.00042	0.000933	CcSEcCtD
Olmesartan—Arthralgia—Topiramate—migraine	0.00042	0.000933	CcSEcCtD
Olmesartan—Myalgia—Topiramate—migraine	0.00042	0.000933	CcSEcCtD
Olmesartan—Anxiety—Topiramate—migraine	0.000418	0.00093	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000417	0.000927	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—HTR1D—migraine	0.000416	0.0127	CbGpPWpGaD
Olmesartan—Decreased appetite—Gabapentin—migraine	0.000416	0.000924	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000416	0.0127	CbGpPWpGaD
Olmesartan—Discomfort—Topiramate—migraine	0.000415	0.000922	CcSEcCtD
Olmesartan—Asthenia—Valproic Acid—migraine	0.000414	0.00092	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Gabapentin—migraine	0.000413	0.000918	CcSEcCtD
Olmesartan—Fatigue—Gabapentin—migraine	0.000412	0.000916	CcSEcCtD
Olmesartan—Pain—Gabapentin—migraine	0.000409	0.000909	CcSEcCtD
Olmesartan—Constipation—Gabapentin—migraine	0.000409	0.000909	CcSEcCtD
Olmesartan—Pruritus—Valproic Acid—migraine	0.000408	0.000907	CcSEcCtD
Olmesartan—Urticaria—Timolol—migraine	0.000408	0.000907	CcSEcCtD
Olmesartan—Abdominal pain—Timolol—migraine	0.000406	0.000902	CcSEcCtD
Olmesartan—Body temperature increased—Timolol—migraine	0.000406	0.000902	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ATP1A2—migraine	0.000405	0.0124	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ATP1A3—migraine	0.000405	0.0124	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000404	0.0123	CbGpPWpGaD
Olmesartan—Oedema—Topiramate—migraine	0.000402	0.000894	CcSEcCtD
Olmesartan—Infection—Topiramate—migraine	0.0004	0.000888	CcSEcCtD
Olmesartan—Shock—Topiramate—migraine	0.000396	0.00088	CcSEcCtD
Olmesartan—Diarrhoea—Valproic Acid—migraine	0.000395	0.000877	CcSEcCtD
Olmesartan—Nervous system disorder—Topiramate—migraine	0.000395	0.000877	CcSEcCtD
Olmesartan—Feeling abnormal—Gabapentin—migraine	0.000394	0.000876	CcSEcCtD
Olmesartan—Thrombocytopenia—Topiramate—migraine	0.000394	0.000876	CcSEcCtD
Olmesartan—Tachycardia—Topiramate—migraine	0.000393	0.000873	CcSEcCtD
Olmesartan—Gastrointestinal pain—Gabapentin—migraine	0.000391	0.000869	CcSEcCtD
Olmesartan—Skin disorder—Topiramate—migraine	0.000391	0.000869	CcSEcCtD
Olmesartan—Hyperhidrosis—Topiramate—migraine	0.000389	0.000865	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—HTR2B—migraine	0.000387	0.0118	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000386	0.0118	CbGpPWpGaD
Olmesartan—Anorexia—Topiramate—migraine	0.000384	0.000852	CcSEcCtD
Olmesartan—ABCC2—Transmembrane transport of small molecules—TRPM8—migraine	0.000383	0.0117	CbGpPWpGaD
Olmesartan—Dizziness—Valproic Acid—migraine	0.000382	0.000848	CcSEcCtD
Olmesartan—Urticaria—Gabapentin—migraine	0.00038	0.000844	CcSEcCtD
Olmesartan—Body temperature increased—Gabapentin—migraine	0.000378	0.00084	CcSEcCtD
Olmesartan—Abdominal pain—Gabapentin—migraine	0.000378	0.00084	CcSEcCtD
Olmesartan—Hypotension—Topiramate—migraine	0.000376	0.000836	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000372	0.0113	CbGpPWpGaD
Olmesartan—Asthenia—Timolol—migraine	0.000369	0.000819	CcSEcCtD
Olmesartan—Vomiting—Valproic Acid—migraine	0.000367	0.000815	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Topiramate—migraine	0.000367	0.000815	CcSEcCtD
Olmesartan—Insomnia—Topiramate—migraine	0.000364	0.000809	CcSEcCtD
Olmesartan—Rash—Valproic Acid—migraine	0.000364	0.000809	CcSEcCtD
Olmesartan—Dermatitis—Valproic Acid—migraine	0.000364	0.000808	CcSEcCtD
Olmesartan—Pruritus—Timolol—migraine	0.000363	0.000808	CcSEcCtD
Olmesartan—Headache—Valproic Acid—migraine	0.000362	0.000803	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—TRPM8—migraine	0.000359	0.011	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000359	0.011	CbGpPWpGaD
Olmesartan—Dyspepsia—Topiramate—migraine	0.000354	0.000787	CcSEcCtD
Olmesartan—ABCC2—NRF2 pathway—SLC6A4—migraine	0.000354	0.0108	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—migraine	0.000352	0.0107	CbGpPWpGaD
Olmesartan—Diarrhoea—Timolol—migraine	0.000351	0.000781	CcSEcCtD
Olmesartan—Decreased appetite—Topiramate—migraine	0.00035	0.000777	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000349	0.0107	CbGpPWpGaD
Olmesartan—Gastrointestinal disorder—Topiramate—migraine	0.000347	0.000772	CcSEcCtD
Olmesartan—Fatigue—Topiramate—migraine	0.000347	0.000771	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—HTR3A—migraine	0.000345	0.0105	CbGpPWpGaD
Olmesartan—Pain—Topiramate—migraine	0.000344	0.000765	CcSEcCtD
Olmesartan—Constipation—Topiramate—migraine	0.000344	0.000765	CcSEcCtD
Olmesartan—Asthenia—Gabapentin—migraine	0.000343	0.000763	CcSEcCtD
Olmesartan—Nausea—Valproic Acid—migraine	0.000343	0.000762	CcSEcCtD
Olmesartan—Dizziness—Timolol—migraine	0.00034	0.000755	CcSEcCtD
Olmesartan—Pruritus—Gabapentin—migraine	0.000338	0.000752	CcSEcCtD
Olmesartan—Feeling abnormal—Topiramate—migraine	0.000332	0.000737	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000331	0.0101	CbGpPWpGaD
Olmesartan—Gastrointestinal pain—Topiramate—migraine	0.000329	0.000731	CcSEcCtD
Olmesartan—Diarrhoea—Gabapentin—migraine	0.000327	0.000727	CcSEcCtD
Olmesartan—Vomiting—Timolol—migraine	0.000327	0.000726	CcSEcCtD
Olmesartan—Rash—Timolol—migraine	0.000324	0.00072	CcSEcCtD
Olmesartan—Dermatitis—Timolol—migraine	0.000324	0.000719	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—CALCRL—migraine	0.000324	0.00988	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—RAMP1—migraine	0.000324	0.00988	CbGpPWpGaD
Olmesartan—Headache—Timolol—migraine	0.000322	0.000715	CcSEcCtD
Olmesartan—Urticaria—Topiramate—migraine	0.00032	0.00071	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000319	0.00972	CbGpPWpGaD
Olmesartan—Abdominal pain—Topiramate—migraine	0.000318	0.000707	CcSEcCtD
Olmesartan—Body temperature increased—Topiramate—migraine	0.000318	0.000707	CcSEcCtD
Olmesartan—Dizziness—Gabapentin—migraine	0.000316	0.000703	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000315	0.0096	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000314	0.00958	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000314	0.00958	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000308	0.00939	CbGpPWpGaD
Olmesartan—Nausea—Timolol—migraine	0.000305	0.000678	CcSEcCtD
Olmesartan—Vomiting—Gabapentin—migraine	0.000304	0.000676	CcSEcCtD
Olmesartan—Rash—Gabapentin—migraine	0.000302	0.00067	CcSEcCtD
Olmesartan—Dermatitis—Gabapentin—migraine	0.000301	0.00067	CcSEcCtD
Olmesartan—Headache—Gabapentin—migraine	0.0003	0.000666	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000299	0.00914	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—RAMP1—migraine	0.000294	0.00897	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CALCRL—migraine	0.000294	0.00897	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ATP1A2—migraine	0.00029	0.00885	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ATP1A3—migraine	0.00029	0.00885	CbGpPWpGaD
Olmesartan—Asthenia—Topiramate—migraine	0.000289	0.000642	CcSEcCtD
Olmesartan—AGTR1—G alpha (q) signalling events—HTR2A—migraine	0.000285	0.0087	CbGpPWpGaD
Olmesartan—Pruritus—Topiramate—migraine	0.000285	0.000633	CcSEcCtD
Olmesartan—Nausea—Gabapentin—migraine	0.000284	0.000631	CcSEcCtD
Olmesartan—Diarrhoea—Topiramate—migraine	0.000275	0.000612	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000272	0.00831	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000272	0.00831	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00027	0.00823	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—TGFBR2—migraine	0.000267	0.00814	CbGpPWpGaD
Olmesartan—Dizziness—Topiramate—migraine	0.000266	0.000591	CcSEcCtD
Olmesartan—Vomiting—Topiramate—migraine	0.000256	0.000569	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000255	0.00778	CbGpPWpGaD
Olmesartan—Rash—Topiramate—migraine	0.000254	0.000564	CcSEcCtD
Olmesartan—Dermatitis—Topiramate—migraine	0.000254	0.000563	CcSEcCtD
Olmesartan—Headache—Topiramate—migraine	0.000252	0.00056	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—HTR1B—migraine	0.000252	0.00769	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—HTR3A—migraine	0.000247	0.00753	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—TNF—migraine	0.000244	0.00745	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—HTR1A—migraine	0.000243	0.0074	CbGpPWpGaD
Olmesartan—Nausea—Topiramate—migraine	0.000239	0.000531	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—NPS—migraine	0.000239	0.00729	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—TAC1—migraine	0.000239	0.00729	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR1D—migraine	0.000235	0.00718	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—HTR2C—migraine	0.000234	0.00715	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—HTR3A—migraine	0.000232	0.00707	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—EDNRA—migraine	0.000228	0.00696	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00022	0.00672	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CALCA—migraine	0.000219	0.0067	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR2B—migraine	0.000219	0.00667	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR1D—migraine	0.000214	0.00652	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—HTR7—migraine	0.000205	0.00626	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR2B—migraine	0.000198	0.00606	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000189	0.00576	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RAMP1—migraine	0.000174	0.0053	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CALCRL—migraine	0.000174	0.0053	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—HTR2A—migraine	0.000144	0.00439	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR1B—migraine	0.000142	0.00435	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CACNA1A—migraine	0.000137	0.00419	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR1A—migraine	0.000137	0.00418	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—NPS—migraine	0.000135	0.00412	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—TAC1—migraine	0.000135	0.00412	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR2C—migraine	0.000132	0.00404	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR1B—migraine	0.000129	0.00395	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—EDNRA—migraine	0.000129	0.00393	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR1D—migraine	0.000126	0.00385	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR1A—migraine	0.000125	0.0038	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CALCA—migraine	0.000124	0.00378	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TAC1—migraine	0.000123	0.00374	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—NPS—migraine	0.000123	0.00374	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR2C—migraine	0.00012	0.00367	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR2B—migraine	0.000117	0.00358	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EDNRA—migraine	0.000117	0.00357	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR7—migraine	0.000116	0.00354	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CALCA—migraine	0.000113	0.00344	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR7—migraine	0.000105	0.00321	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LRP1—migraine	0.000103	0.00315	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CACNA1A—migraine	9.22e-05	0.00281	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR2A—migraine	8.12e-05	0.00248	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOTCH4—migraine	7.92e-05	0.00242	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR1B—migraine	7.64e-05	0.00233	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR2A—migraine	7.38e-05	0.00225	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR1A—migraine	7.36e-05	0.00224	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPS—migraine	7.24e-05	0.00221	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PGR—migraine	7.24e-05	0.00221	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TAC1—migraine	7.24e-05	0.00221	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR2C—migraine	7.1e-05	0.00217	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDNRA—migraine	6.91e-05	0.00211	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOTCH3—migraine	6.73e-05	0.00206	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CALCA—migraine	6.65e-05	0.00203	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR7—migraine	6.22e-05	0.0019	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFBR2—migraine	5.36e-05	0.00164	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTHFR—migraine	4.54e-05	0.00139	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR2A—migraine	4.36e-05	0.00133	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ESR1—migraine	3.87e-05	0.00118	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTHFR—migraine	3.05e-05	0.000931	CbGpPWpGaD
